Mark Woodruff

1.0k citations
10 papers · 543 · 1 hit paper · h-index 4

Impact in

    • Lymphoma Diagnosis and Treatment
    • Epigenetics and DNA Methylation
    • Histone Deacetylase Inhibitors Research
    • Cancer-related gene regulation
    • Protein Degradation and Inhibitors
    • Chromatin Remodeling and Cancer
    • RNA modifications and cancer

Papers in

    • Cardiac electrophysiology and arrhythmias 3
    • Cardiac pacing and defibrillation studies 2
    • Cardiomyopathy and Myosin Studies 2
    • Cardiovascular Function and Risk Factors 2
    • Ion channel regulation and function 2
    • Chromatin Remodeling and Cancer 1

Mark Woodruff

8 papers receiving 529 citations

Mark Woodruff's Hit Papers

Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study 2018 · 451 citations
4510+2+5Years since publication100200300400

Peers

Mark Woodruff
Comparison fields: 5 of 61
  • Pathology and Forensic Medicine 115
  • Molecular Biology 346
  • Oncology 117
  • Cancer Research 64
  • Cardiology and Cardiovascular Medicine 79
Replace T. Megha with:
T. Megha Italy
Genevieve A. Andrews United States
Ying A. Wang United States
Joseph Eid United States
J. Crawford United States
Carbone Pp United States
Jason B. Litten United States
Ayako Mitsuma Japan
Jeremiah J. Andersen United States
Maciej Kaźmierczak Poland
Mark Woodruff relative to T. Megha Italy T. Megha's profile →
Citations per field
00.5×10×13.4×
T. Megha · 1×
Citations per year

Countries citing papers authored by Mark Woodruff

Since Specialization
Citations

This map shows the geographic impact of Mark Woodruff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Woodruff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Woodruff more than expected).

Fields of papers citing papers by Mark Woodruff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Woodruff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Woodruff. The network helps show where Mark Woodruff may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Woodruff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Woodruff Line = papers co-authored together Mark Woodruff links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1
Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study
Hit paper breakdown →
2018451
2 198454
3 198720
4 200011
5 19893
6 20101
7 19891
8 19951
9 20101
10 20140

About Mark Woodruff

Mark Woodruff is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Organic Chemistry, Surgery and Pathology and Forensic Medicine, having authored 10 papers that have together received 543 indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (3 papers), Ion channel regulation and function (2 papers), Cardiac pacing and defibrillation studies (2 papers), Cardiomyopathy and Myosin Studies (2 papers), Cardiovascular Function and Risk Factors (2 papers), Chemical Thermodynamics and Molecular Structure (1 paper), Chromatin Remodeling and Cancer (1 paper) and Health Systems, Economic Evaluations, Quality of Life (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (115 citations), Molecular Biology (346 citations), Oncology (117 citations), Cancer Research (64 citations) and Cardiology and Cardiovascular Medicine (79 citations). Mark Woodruff has collaborated with scholars based in United States, France and Brazil. Frequent co-authors include Alicia Clawson, Heike Keilhack, Takashi Owa, Stephen J. Blakemore, Andréa Varga, Vincent Ribrag, Jean‐Marie Michot, Scott Ribich, Jean‐Michel Coindre and Benjamin Suttle. Their work appears in journals such as Journal of Cardiovascular Pharmacology, The American Journal of Cardiology, The Lancet Oncology, Rapid Communications in Mass Spectrometry and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact